0000899243-18-018100.txt : 20180626 0000899243-18-018100.hdr.sgml : 20180626 20180626141445 ACCESSION NUMBER: 0000899243-18-018100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180621 FILED AS OF DATE: 20180626 DATE AS OF CHANGE: 20180626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peterson Kristine CENTRAL INDEX KEY: 0001508596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 18919031 MAIL ADDRESS: STREET 1: AMARIN CORPORATION STREET 2: MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE CITY: MYSTIC STATE: CT ZIP: 06355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-21 0 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001508596 Peterson Kristine C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 1 0 0 0 Employee Stock Option (right to buy) 1.95 2018-06-21 4 A 0 26667 0.00 A 2019-06-21 2028-06-21 Common Stock 26667 26667 D Deferred Stock Units 2018-06-21 4 A 0 6667 0.00 A 2019-06-21 Common Stock 6667 6667 D Employee Stock Option (right to buy) 1.95 2018-06-21 4 A 0 40000 0.00 A 2028-06-21 Common Stock 40000 40000 D Each deferred stock unit represents the right to receive one share of the common stock of EyePoint Pharmaceuticals, Inc. (the "Company"). Subsequent to the vesting of the deferred stock units, the deferred stock units will be settled in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a "change in control" (as defined in the applicable award agreement) that constitutes a "change in the ownership or effective control of" the Company or "a change in the ownership of a substantial portion of the assets of" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder. The option becomes exercisable in two equal annual installments beginning on June 21, 2019. /s/ John Mercer, Attorney-in-Fact 2018-06-26